Valuation: Omnicell, Inc.

Market Cap 1.65B 1.48B 1.36B 1.24B 2.35B 155B 2.41B 16.34B 6.51B 82.95B 6.2B 6.07B 262B P/E 2026 *
32.4x
P/E 2027 * 40.4x
Enterprise Value 1.65B 1.48B 1.36B 1.24B 2.35B 155B 2.41B 16.34B 6.51B 82.95B 6.2B 6.07B 262B EV / Sales 2026 *
1.34x
EV / Sales 2027 * 1.33x
Free-Float
76.56%
Yield 2026 *
-
Yield 2027 * -
1 day-3.88%
1 week+1.24%
Current month-2.05%
1 month+0.22%
3 months-3.78%
6 months-18.07%
Current year-20.75%
1 week 34.9
Extreme 34.9
40.1
1 month 34.9
Extreme 34.9
40.1
Current year 31.75
Extreme 31.75
55
1 year 31.75
Extreme 31.75
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 30/09/2002
Director of Finance/CFO 56 14/09/2025
President 50 30/06/2026
Director TitleAgeSince
Chairman 68 31/08/1992
Director/Board Member 70 31/12/2012
Director/Board Member 70 31/12/2013
Date Insider Type Main position Quantity % Market Cap. Importance
17/08/26 Sell

Chairperson

-3,083 0.0068%
15/08/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/08/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-3.88%+1.24%-2.47%+16.71% 1.65B
-0.48%+2.84%+24.61%+60.16% 266B
+0.42%+2.61%+11.81%+19.85% 166B
-2.28%+2.11%-21.90%+62.18% 156B
+1.54%+2.76%-55.70%-13.30% 64.79B
-0.67%+9.27%+23.70%+61.98% 59.81B
+0.71%-0.95%-0.97%-9.81% 53.3B
-1.27%+1.38%+21.54%+63.99% 50.15B
-0.28%+0.77%+3.31%+85.09% 49.47B
-0.25%+3.40%+26.28%+85.81% 46.72B
Average -0.65%+2.90%+3.02%+43.27% 91B
Weighted average by Cap. -0.45%+2.99%+5.82%+46.80%

Financials

2026 *2027 *
Net sales 1.23B 1.1B 1.02B 922M 1.75B 115B 1.79B 12.16B 4.84B 61.71B 4.61B 4.51B 195B 1.24B 1.11B 1.02B 931M 1.76B 116B 1.81B 12.27B 4.89B 62.28B 4.65B 4.55B 197B
Net income 51.55M 46.23M 42.61M 38.69M 73.23M 4.83B 75.28M 510M 203M 2.59B 193M 189M 8.19B 41.64M 37.35M 34.42M 31.26M 59.16M 3.9B 60.81M 412M 164M 2.09B 156M 153M 6.61B
Net Debt - -
Projected Income Statement - Annual - Omnicell, Inc.
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,450
Date Price Change Volume
10/11/26 US$35.90 -3.88% 560,198
09/11/26 US$37.35 +0.03% 495,902
06/11/26 US$37.34 -1.81% 562,787
05/11/26 US$38.03 -3.50% 783,367
04/11/26 US$39.41 +11.14% 850,497
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - Omnicell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
35.90USD
Average target price
57.43USD
Spread / Average Target
+59.97%
  1. Stock Market
  2. Stocks
  3. OMCL Stock